CNBC Television published this video item, entitled “Cantor Fitzgerald’s Alethia Young on FDA approval for Biogen drug” – below is their description.
Cantor Fitzgerald senior biotech analyst Alethia Young joins ‘Closing Bell’ to discuss the FDA approval for Biogen’s Alzheimer’s drug, calling this “one of the biggest approvals in biotech’s history.”CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.